Dr. Burgin, a professor of neurology and stroke division chief at the University of South Florida, brings a wealth of expertise to the field of neurology, including clinical care, research, administration, and teaching. His extensive background includes a deep focus on stroke-related artificial intelligence (AI), biomarkers, and intellectual property (IP) development. Throughout his distinguished career, Dr. Burgin has made significant contributions to the medical community, evidenced by his authorship of over 100 peer-reviewed articles and active contributions to more than 75 clinical research projects.

Dr. Burgin is passionate about leveraging innovative technologies to enhance patient outcomes. In addition to his role on the NeuroEM medical advisory board, he currently serves as the Chief Medical Advisor for a biotechnology company in Tampa. He has also co-founded two pioneering companies in the Tampa Bay region. One focuses on novel neuroprotectant approaches, exploring new methods to safeguard and restore neural function. The other harnesses the power of AI to assist stroke patients with communication disorders, fostering improved communication and increased independence.

By combining his academic prowess with his entrepreneurial spirit, Dr. Burgin continues to make a lasting impact on the neurological community and beyond.

LinkedIn Profile